{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:58:11Z","timestamp":1790380691313,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Context: Mutations in the Kir6.2 subunit (KCNJ11) of the ATP-sensitive potassium channel (KATP) underlie neonatal diabetes mellitus. In severe cases, Kir6.2 mutations underlie developmental delay, epilepsy, and neonatal diabetes (DEND). All Kir6.2 mutations examined decrease the ATP inhibition of KATP, which is predicted to suppress electrical activity in neurons (peripheral and central), muscle, and pancreas. Inhibitory sulfonylureas (SUs) have been used successfully to treat diabetes in patients with activating Kir6.2 mutations. There are two reports of improved neurological features in SU-treated DEND patients but no report of such improvement in adulthood.<\/jats:p><jats:p>Objective: The objective of the study was to determine the molecular basis of intermediate DEND in a 27-yr-old patient with a KCNJ11 mutation (G53D) and the patient\u2019s response to SU therapy.<\/jats:p><jats:p>Design: The G53D patient was transferred from insulin to gliclazide and then to glibenclamide over a 160-d period. Motor function was assessed throughout. Electrophysiology assessed the effect of the G53D mutation on KATP activity.<\/jats:p><jats:p>Results: The G53D patient demonstrated improved glycemic control and motor coordination with SU treatment, although glibenclamide was more effective than gliclazide. Reconstituted G53D channels exhibit reduced ATP sensitivity, which is predicted to suppress electrical activity in vivo. G53D channels coexpressed with SUR1 (the pancreatic and neuronal isoform) exhibit high-affinity block by gliclazide but are insensitive to block when coexpressed with SUR2A (the skeletal muscle isoform). High-affinity block by glibenclamide is present in G53D channels coexpressed with either SUR1 or SUR2A.<\/jats:p><jats:p>Conclusion: The results demonstrate that SUs can resolve motor dysfunction in an adult with intermediate DEND and that this improvement is due to inhibition of the neuronal but not skeletal muscle KATP.<\/jats:p>","DOI":"10.1210\/jc.2007-1826","type":"journal-article","created":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T04:47:23Z","timestamp":1197434843000},"page":"1054-1061","source":"Crossref","is-referenced-by-count":89,"title":["The G53D Mutation in Kir6.2 (KCNJ11) Is Associated with Neonatal Diabetes and Motor Dysfunction in Adulthood that Is Improved with Sulfonylurea Therapy"],"prefix":"10.1210","volume":"93","author":[{"given":"Joseph C.","family":"Koster","sequence":"first","affiliation":[{"name":"Department of Cell Biology and Physiology (J.C.K., C.G.N.), Washington University School of Medicine, St. Louis, Missouri 63110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cadario","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (F.C.), Azienda Ospedaliera \u201cMaggiore della Carita,\u201d 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Peruzzi","sequence":"additional","affiliation":[{"name":"Interdisciplinary Research Center for Autoimmune Disease, A. Avogadro University of Eastern Piedmont, and Division of Child Neurology and Psychiatry (C.P.), Azienda Ospedaliera \u201cMaggiore della Carita,\u201d 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Colombo","sequence":"additional","affiliation":[{"name":"Bambino Gesu Children\u2019s Hospital (C.C., F.B.), Instituto di Ricovero e Cura a Carattere Scientifico, 00164 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin G.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology (J.C.K., C.G.N.), Washington University School of Medicine, St. Louis, Missouri 63110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Barbetti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (F.B.), University of Tor Vergata, 00133 Rome, Italy"},{"name":"Department of S. Raffaele Scientific Park Foundation (F.B.), 00128 Rome, Italy"},{"name":"Bambino Gesu Children\u2019s Hospital (C.C., F.B.), Instituto di Ricovero e Cura a Carattere Scientifico, 00164 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613423771900_R1","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071613423771900_R2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)80701-1","article-title":"Targeted overactivity of \\#946; \\#946; cell K(ATP) channels induces profound neonatal diabetes.","volume":"100","author":"Koster","year":"2000","journal-title":"Cell"},{"key":"2020071613423771900_R3","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1210\/jc.2004-1241","article-title":"Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.","volume":"89","author":"Zung","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613423771900_R4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20124","article-title":"KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.","volume":"25","author":"Massa","year":"2005","journal-title":"Hum Mutat"},{"key":"2020071613423771900_R5","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","article-title":"Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.","volume":"53","author":"Sagen","year":"2004","journal-title":"Diabetes"},{"key":"2020071613423771900_R6","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2337\/diabetes.53.10.2719","article-title":"Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients.","volume":"53","author":"Vaxillaire","year":"2004","journal-title":"Diabetes"},{"key":"2020071613423771900_R7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/hmg\/ddi086","article-title":"Relapsing diabetes can result from moderately activating mutations in KCNJ11.","volume":"14","author":"Gloyn","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2020071613423771900_R8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071613423771900_R9","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00125-006-0246-z","article-title":"Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.","volume":"49","author":"Flanagan","year":"2006","journal-title":"Diabetologia"},{"key":"2020071613423771900_R10","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/diabetes.54.9.2645","article-title":"ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy.","volume":"54","author":"Koster","year":"2005","journal-title":"Diabetes"},{"key":"2020071613423771900_R11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/07853890510007287","article-title":"Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment.","volume":"37","author":"Slingerland","year":"2005","journal-title":"Ann Med"},{"key":"2020071613423771900_R12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071613423771900_R13","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00125-006-0407-0","article-title":"Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.","volume":"49","author":"Slingerland","year":"2006","journal-title":"Diabetologia"},{"key":"2020071613423771900_R14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/01.wnl.0000268488.51776.53","article-title":"A novel mutation causing DEND syndrome.","volume":"69","author":"Shimomura","year":"2007","journal-title":"Neurology"},{"key":"2020071613423771900_R15","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","article-title":"Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.","volume":"49","author":"Tonini","year":"2006","journal-title":"Diabetologia"},{"key":"2020071613423771900_R16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/bbrc.1996.1689","article-title":"Sulfonylureas stimulate glucose uptake through GLUT4 transporter translocation in rat skeletal muscle.","volume":"228","author":"Pulido","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071613423771900_R17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1085\/jgp.110.6.655","article-title":"Octameric stoichiometry of the KATP channel complex.","volume":"110","author":"Shyng","year":"1997","journal-title":"J Gen Physiol"},{"key":"2020071613423771900_R18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0896-6273(00)80321-9","article-title":"Association and stoichiometry of K(ATP) channel subunits.","volume":"18","author":"Clement","year":"1997","journal-title":"Neuron"},{"key":"2020071613423771900_R19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-5793(97)00488-2","article-title":"Subunit stoichiometry of the pancreatic \u03b2-cell ATP-sensitive K+ channel.","volume":"409","author":"Inagaki","year":"1997","journal-title":"FEBS Lett"},{"key":"2020071613423771900_R20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/387179a0","article-title":"Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.","volume":"387","author":"Tucker","year":"1997","journal-title":"Nature"},{"key":"2020071613423771900_R21","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1074\/jbc.274.7.3931","article-title":"Direct photoaffinity labeling of the Kir6.2 subunit of the ATP-sensitive K+ channel by 8-azido-ATP.","volume":"274","author":"Tanabe","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071613423771900_R22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.272.5269.1785","article-title":"Adenosine diphosphate as an intracellular regulator of insulin secretion.","volume":"272","author":"Nichols","year":"1996","journal-title":"Science"},{"key":"2020071613423771900_R23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0896-6273(00)80124-5","article-title":"A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.","volume":"16","author":"Inagaki","year":"1996","journal-title":"Neuron"},{"key":"2020071613423771900_R24","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2337\/diabetes.47.9.1412","article-title":"Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.","volume":"47","author":"Gribble","year":"1998","journal-title":"Diabetes"},{"key":"2020071613423771900_R25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s001250051236","article-title":"Differential sensitivity of \u03b2-cell and extrapancreatic K(ATP) channels to gliclazide.","volume":"42","author":"Gribble","year":"1999","journal-title":"Diabetologia"},{"key":"2020071613423771900_R26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1469-7793.1997.00035.x","article-title":"The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation.","volume":"504","author":"Gribble","year":"1997","journal-title":"J Physiol"},{"key":"2020071613423771900_R27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.emboj.7600487","article-title":"Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit.","volume":"24","author":"Antcliff","year":"2005","journal-title":"EMBO J"},{"key":"2020071613423771900_R28","doi-asserted-by":"crossref","first-page":"17539","DOI":"10.1073\/pnas.0404756101","article-title":"Molecular basis of Kir6.2 mutations associated with neonatal diabetes plus neurological features.","volume":"101","author":"Proks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613423771900_R29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1900\/RDS.2006.3.17","article-title":"Assessment of insulin sensitivity in adults with permanent neonatal diabetes mellitus due to mutations in the KCNJ11 gene encoding Kir6.2.","volume":"3","author":"Skupien","year":"2006","journal-title":"Rev Diabet Stud"},{"key":"2020071613423771900_R30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1073\/pnas.0505974103","article-title":"Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties.","volume":"103","author":"Tricarico","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613423771900_R31","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1073\/pnas.201390398","article-title":"Disruption of Sur2-containing KATP channels enhances insulin-stimulated glucose uptake in skeletal muscle.","volume":"98","author":"Chutkow","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613423771900_R32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0306-4522(94)90231-3","article-title":"Localization of high affinity [3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain.","volume":"61","author":"Hicks","year":"1994","journal-title":"Neuroscience"},{"key":"2020071613423771900_R33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/emboj\/18.4.833","volume":"18","author":"Liss","journal-title":"EMBO J"},{"key":"2020071613423771900_R34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/jps.2600731204","article-title":"Pharmacokinetics of gliclazide in healthy and diabetic subjects.","volume":"73","author":"Kobayashi","year":"1984","journal-title":"J Pharm Sci"},{"key":"2020071613423771900_R35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/dc06-1628","volume":"30","author":"Malecki","journal-title":"Diabetes Care"},{"key":"2020071613423771900_R36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.2042-7158.1998.tb06918.x","article-title":"Efflux transport of tolbutamide across the blood-brain barrier.","volume":"50","author":"Takanaga","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"2020071613423771900_R37","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/ddl101","article-title":"A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes","volume":"15","author":"Proks","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2020071613423771900_R38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/db06-1275","article-title":"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.","volume":"56","author":"Masia","year":"2007","journal-title":"Diabetes"},{"key":"2020071613423771900_R39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1152\/ajpendo.00313.2002","article-title":"ATP-sensitive potassium channels participate in glucose uptake in skeletal muscle and adipose tissue.","volume":"283","author":"Miki","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613423771900_R40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF00400409","article-title":"Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K+ channel dependent mechanism.","volume":"39","author":"Pulido","year":"1996","journal-title":"Diabetologia"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/3\/1054\/9057452\/jcem1054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/3\/1054\/9057452\/jcem1054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T07:29:26Z","timestamp":1684135766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/3\/1054\/2598918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1826","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}